CompletedNot Applicable

COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT

Egypt20 participantsStarted 2025-02-01

Plain-language summary

The intra-articular injection is considered the first line of minimally invasive treatment of joint disease as it has an analgesic, antimicrobial effect and an immune system stimulating action as it is one of the most powerful detoxication agents.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients above 18 years old.
✓. Patients suffering from sounds during condylar movements (clicking or popping).
✓. Patients suffering from limited mouth opening and impaired joint movements.
✓. Patients who did not respond to conservative treatment as a first line of treatment.

Exclusion criteria

✕. Patients with history of condylar fracture.
✕. Patients with degenerative joint disease.
✕. Coagulopathy blood disorders.
✕. Presence of infection at the site of injection.

What they're measuring

Helkimo's Index

Timeframe: 6 months

Trial details

NCT IDNCT07523451

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-30

View on ClinicalTrials.gov More TMJ Disc Disorder trials